pre_text: The primary components of the deferred tax assets and liabilities are as follows, for the periods indicated below: We believe that sufficient uncertainty exists regarding the realization of certain deferred tax assets that a valuation allowance is required. We continue to evaluate our taxable position quarterly and consider factors by taxing jurisdiction, including but not limited to factors such as estimated taxable income, any historical experience of losses for tax purposes and the future growth of OpenText.
table: June 30,
table: 2019 2018
table: Deferred tax assets
table: Non-capital loss carryforwards $161,119 $129,436
table: Capital loss carryforwards 155 417
table: Undeducted scientific research and development expenses 137,253 123,114
table: Depreciation and amortization 683,777 829,369
table: Restructuring costs and other reserves 17,845 17,202
table: Deferred revenue 53,254 62,726
table: Other 59,584 57,461
table: Total deferred tax asset $1,112,987 $1,219,725
table: Valuation Allowance $(77,328) $(80,924)
table: Deferred tax liabilities
table: Scientific research and development tax credits $(14,482) $(13,342)
table: Other (72,599) (82,668)
table: Deferred tax liabilities $(87,081) $(96,010)
table: Net deferred tax asset $948,578 $1,042,791
table: Comprised of:
table: Long-term assets 1,004,450 1,122,729
table: Long-term liabilities (55,872) (79,938)
table: $948,578 $1,042,791
question: Analyse this data from a financial earnings document. What is the percentage change of total assets from fiscal year 2018 to 2019?